Immunotherapy – Asian Pacific Journal of Allergy and Immunology

January 14, 2024

Diving deep into fish allergen immunotherapy: Current knowledge and future directions

Fish allergy is one of the “big nine” categories of food allergens worldwide, and its prevalence is increasing with the higher demand for this nutritious food source.

allergen, Anaphylaxis, Component Resolved Diagnostics, fish allergy, Immunotherapy, vaccine

April 23, 2023

Safety of House Dust Mite Subcutaneous Immunotherapy with a rush and cluster combination protocol in the build-up phase

Conventional and cluster subcutaneous immunotherapy (SCIT) are effective but may be time-consuming. Rush SCIT may offer a more convenient treatment option to patients and be of shorter duration; however, it is also associated with a higher incidence of systemic adverse reactions. Therefore, a combination of protocols between rush and cluster SCIT could have a superior risk-benefit ratio.

allergen, house dust mites, Immunotherapy, risk factor, safety

January 23, 2023

Allergen immunotherapy for respiratory allergies in clinical practice: A comprehensive review

Allergen-specific immunotherapy (AIT) is the only treatment that modifies the underlying pathophysiology of IgE-mediated allergic diseases.

allergen, Allergic rhinitis, Allergy, Asthma, Immunotherapy

March 14, 2022

Field sting reactions in patients receiving Hymenoptera venom immunotherapy: real-life experience

Hymenoptera stings can cause systemic allergic reactions (SARs) that are prevented by venom immunotherapy (VIT). Sting challenge tests or field stings are used to evaluate the outcome of VIT.

ACE inhibitor, adverse effects, common wasp venom, field sting, honeybee venom, Immunotherapy, Insect allergy, local allergic reaction, severity of index reaction, sting reactions, systemic allergic reaction

November 7, 2020

A comparison of cell-culture plasticwares for effective human cytokine-induced killer cell culture

Cytokine-induced killer (CIK) cells are ex-vivo expanded T cells which present a phenotype of both T and Natural Killer cell properties.

cell culture plasticware, cytokine-induced killer cells, gas-permeable flask, Immunotherapy, static bag

July 13, 2020

Efficacy, patients’ perception, and cost of medication in allergic rhinitis with subcutaneous immunotherapy

Allergic rhinitis (AR) is the allergic inflammation of nasal mucosa. Treatment of AR includes pharmacotherapy and allergen immunotherapy. Subcutaneous immunotherapy (SCIT) is indicated in inadequate disease control, patient’s preference, or impossible allergen avoidance. SCIT is an effective treatment but its cost is comparatively high. Efficacy, patient perception, and cost of medication are rarely explored in Asia.

cost-benefit, efficacy, Immunotherapy, perception, safety